| | | | |
Children's Health
|
The Effect of Chelation on Blood Pressure in Lead-Exposed Children: A Randomized Study Aimin Chen,1 George G. Rhoads,2 Bo Cai,3 Mikhail
Salganik,4 and Walter J. Rogan1 1Epidemiology Branch, National Institute of Environmental Health
Sciences, National Institutes of Health, U.S. Department of Health and Human
Services, Research Triangle Park, North Carolina, USA; 2Environmental
and Occupational Health Sciences Institute, University of Medicine and Dentistry
of New Jersey, Piscataway, New Jersey, USA; 3Biostatistics Branch,
National Institute of Environmental Health Sciences, National Institutes of
Health, U.S. Department of Health and Human Services, Research Triangle Park,
North Carolina, USA; 4Harvard School of Public Health, Harvard University,
Boston, Massachusetts, USA Abstract Studies in children suggest a weak association between blood lead concentration and blood pressure. To understand this better, we tested the strength of the association in children with elevated blood lead concentrations and whether succimer chelation changed blood pressure as it did blood lead. In a randomized clinical trial of 780 children with blood lead concentrations of 20-44 µg/dL at 12-33 months of age, we compared the systolic and diastolic blood pressure in the succimer-treated group and placebo group for up to 5 years of follow-up. We also analyzed the relation of blood lead to blood pressure. Children in the succimer group had lower blood lead concentrations for 9-10 months during and after treatment, but their blood pressure did not differ from those in the placebo group during this period. During 1-5 years of follow-up, children in the succimer group had systolic blood pressure 1.09 (95% confidence interval, 0.27-1.90) mmHg higher than did untreated children in a model with repeated measurements, but the difference in diastolic blood pressure was not statistically significant. No association between blood lead and blood pressure was found. Overall, there is no association between blood lead and blood pressure in these children with moderately high lead exposure, nor does chelation with succimer change blood pressure. Key words: blood pressure, chelation, child, lead, succimer. Environ Health Perspect 114:579-583 (2006) . doi:10.1289/ehp.8634 available via http://dx.doi.org/ [Online 24 January 2006]
Address correspondence to W.J. Rogan, Epidemiology Branch, NIEHS, MD A3-05, P.O. Box 12233, Research Triangle Park, NC 27709 USA. Telephone: (919) 541-4578. Fax: (919) 541-2511. E-mail: rogan@niehs.nih.gov The Treatment of Lead-Exposed Children trial was supported by NIEHS in cooperation with the National Institutes of Health Office of Minority Health, and by the Centers for Disease Control and Prevention. Succimer and placebo capsules were gifts from McNeil Laboratories, Fort Washington, PA. The authors declare they have no competing financial interests. Received 6 September 2005 ; accepted 23 January 2006. |
|
|
|
|
|
[References Listed in PubMed] References
Akaike H. 1974. A new look at the statistical
model identification. IEEE Trans Auto
Control 19(6): 716-723.
ATSDR. 1999. Toxicological Profile
for Lead. Atlanta, GA:Agency for Toxic
Substances and Disease Registry.
Chai SS, Webb RC. 1988. Effects of
lead on vascular reactivity. Environ
Health Perspect 78:85-89.
Cheng Y, Schwartz J, Sparrow D, Aro
A, Weiss ST, Hu H. 2001. Bone lead and
blood lead levels in relation to baseline
blood pressure and the prospective development
of hypertension: the Normative Aging
Study. Am J Epidemiol 153:164-171.
de Kort WL, Verschoor MA, Wibowo AA,
van Hemmen JJ. 1987. Occupational exposure
to lead and blood pressure: a study in
105 workers. Am J Ind Med 11: 145-156.
Den Hond E, Nawrot T, Staessen JA.
2002. The relationship between blood
pressure and blood lead in NHANES III.
National Health and Nutritional Examination
Survey. J Hum Hypertens 16:563-568.
Den Hond E, Nawrot T, Staessen JA.
2003. Hypertension and low-level lead
exposure: a scientific issue or a matter
of faith? [Letter]. Hypertension 42:e9.
doi: 10.1161/01.HYP.0000085859.22259.42
[Online 28 July 2003].
Dietrich KN, Ware JH, Salganik M, Radcliffe
J, Rogan WJ, Rhoads GG, et al. 2004.
Effect of chelation therapy on the neuropsychological
and behavioral development of lead-exposed
children after school entry. Pediatrics
114:19-26.
Ding Y, Vaziri ND, Gonick HC. 1998.
Lead-induced hypertension. II. Response
to sequential infusions of l-arginine,
superoxide dismutase, and nitroprusside.
Environ Res 76:107-113.
Factor-Litvak P, Kline JK, Popovac
D, Hadzialjevic S, Lekic V, Preteni-Rexhepi
E, et al. 1996. Blood lead and blood
pressure in young children. Epidemiology
7: 633-637.
Fewtrell LJ, Pruss-Ustun A, Landrigan
P, Ayuso-Mateos JL. 2004. Estimating
the global burden of disease of mild
mental retardation and cardiovascular
diseases from environmental lead exposure.
Environ Res 94:120-133.
Friedlander MA, Brooks CT, Sheehe PR.
1981. Blood pressure and creatinine clearance
in lead-exposed children: the effect
of treatment. Arch Environ Health 36:
310-315.
Gillman MW, Cook NR. 1995. Blood pressure
measurement in childhood epidemiological
studies. Circulation 92:1049-1057.
Gillman MW, Hood MY, Moore LL, Nguyen
US, Singer MR, Andon MB. 1995. Effect
of calcium supplementation on blood pressure
in children. J Pediatr 127:186-192.
Gillman MW, Oliveria SA, Moore LL,
Ellison RC. 1992. Inverse association
of dietary calcium with systolic blood
pressure in young children. JAMA 267:2340-2343.
Graziano JH, Lolacono NJ, Meyer P.
1988. Dose-response study of oral 2,3-dimercaptosuccinic
acid in children with elevated blood
lead concentrations. J Pediatr 113: 751-757.
Hertz-Picciotto I, Croft J. 1993. Review
of the relation between blood lead and
blood pressure. Epidemiol Rev 15:352-373.
Hu H. 1991. A 50-year follow-up of
childhood plumbism. Hypertension, renal
function, and hemoglobin levels among
survivors. Am J Dis Child 145: 681-687.
Jhaveri RC, Lavorgna L, Dube SK, Glass
L, Khan F, Evans HE. 1979. Relationship
of blood pressure to blood lead concentrations
in small children. Pediatrics 63: 674-676.
Miller DT, Paschal DC, Gunter EW, Stroud
PE, D’Angelo J. 1987. Determination
of lead in blood using electrothermal
atomisation atomic absorption spectrometry
with a L’vov platform and matrix
modifier. Analyst 112: 1701-1704.
Nash D, Magder L, Lustberg M, Sherwin
RW, Rubin RJ, Kaufmann RB, et al. 2003.
Blood lead, blood pressure, and hypertension
in perimenopausal and postmenopausal
women. JAMA 289:1523-1532.
National High Blood Pressure Education
Program. 2004. National High Blood Pressure
Education Program Working Group on High
Blood Pressure in Children and Adolescents.
The fourth report on the diagnosis, evaluation,
and treatment of high blood pressure
in children and adolescents. Pediatrics
114:555-576.
Nawrot TS, Thijs L, Den Hond EM, Roels
HA, Staessen JA. 2002. An epidemiological
re-appraisal of the association between
blood pressure and blood lead: a meta-analysis.
J Hum Hypertens 16:123-131.
Pirkle JL, Kaufmann RB, Brody DJ, Hickman
T, Gunter EW, Paschal DC. 1998. Exposure
of the U.S. population to lead, 1991-1994.
Environ Health Perspect 106: 745-750.
Preuss HG, Jiang G, Jones JW, Macarthy
PO, Andrews PM, Gondal JA. 1994. Early
lead challenge and subsequent hypertension
in Sprague-Dawley rats. J Am Coll Nutr
13:578-583.
R Development Core Team. 2004. R: A
Language and Environment for Statistical
Computing. Vienna:R Foundation for Statistical
Computing.
Rogan WJ, Dietrich KN, Ware JH, Dockery
DW, Salganik M, Radcliffe J, et al. 2001.
The effect of chelation therapy with
succimer on neuropsychological development
in children exposed to lead. N Engl J
Med 344: 1421-1426.
Rogan WJ, Hogan MD, Chi PY, Cowan D.
1978. Blood pressure and lead levels
in children. J Environ Pathol Toxicol
2:517-519.
Rothenberg SJ, Kondrashov V, Manalo
M, Jiang J, Cuellar R, Garcia M, et al.
2002. Increases in hypertension and blood
pressure during pregnancy with increased
bone lead levels. Am J Epidemiol 156:1079-1087.
Selbst SM, Sokas RK, Henretig FM, Weller
SC, Tershakovec AM. 1993. The effect
of blood lead on blood pressure in children.
J Environ Pathol Toxicol Oncol 12: 213-218.
Sharp DS, Becker CE, Smith AH. 1987.
Chronic low-level lead exposure. Its
role in the pathogenesis of hypertension.
Med Toxicol 2:210-232.
Sinaiko AR. 1996. Hypertension in children.
N Engl J Med 335:1968-1973.
Staessen JA, Lauwerys RR, Bulpitt CJ,
Fagard R, Lijnen P, Roels H, et al. 1994.
Is a positive association between lead
exposure and blood pressure supported
by animal experiments? Curr Opin Nephrol
Hypertens 3: 257-263.
Telisman S, Pizent A, Jurasovic J,
Cvitkovic P. 2004. Lead effect on blood
pressure in moderately lead-exposed male
workers. Am J Ind Med 45:446-454.
TLC Trial. 1998. The Treatment of Lead-Exposed
Children (TLC) trial: design and recruitment
for a study of the effect of oral chelation
on growth and development in toddlers.
Paediatr Perinat Epidemiol 12:313-333.
Victery W. 1988. Evidence for effects
of chronic lead exposure on blood pressure
in experimental animals: an overview.
Environ Health Perspect 78:71-76.
Victery W, Vander AJ, Markel H, Katzman
L, Shulak JM, Germain C. 1982a. Lead
exposure, begun in utero, decreases
renin and angiotensin II in adult rats.
Proc Soc Exp Biol Med 170:63-67.
Victery W, Vander AJ, Shulak JM, Schoeps
P, Julius S. 1982b. Lead, hypertension,
and the renin-angiotensin system in rats.
J Lab Clin Med 99: 354-362.
Vupputuri S, He J, Muntner P, Bazzano
LA, Whelton PK, Batuman V. 2003. Blood
lead level is associated with elevated
blood pressure in blacks. Hypertension
41: 463-468.
Last Updated: March 14, 2006 |
|
|
|
| |